Greys Anatomy Season 16: When Is It Scheduled For Netflix Release? Premiere Date And Other Details – The Digital Weekly

Anatomy of Fan-Favorite Grey remains a large part of the Netflix lineup. When are you looking for the current season, season 16, to get to Netflix? Think about the release schedule for season 16 of Greys Anatomy on Netflix.

Greys Anatomy has been an important force in the American ABC network and is one of the most popular primetime programs on American television. The series has undergone many changes in the last fifteen seasons, but a constant that remains is Ellen Pompeo starring Meredith Gray.

The record series continues to take them out of the park in the direction of the sixteenth season. Greys Anatomy is not only the oldest scripted primetime by ABC, but it is also the longest-running American medical drama series of ER.

When is Greys Anatomy season 16 on Netflix US?

Usually, the last seasons of Greys Anatomy come to summer on Netflix. The fifteenth season concluded on June 15, approximately one month after the end of ABC.

From previous years, ABC is set for the series to arrive in May 2020.

We expect season sixteen to end in late April or early May. A month after the end, Netflix should have a season of approximately sixteen months.

Fans will be happy to know that Greys Anatomy was renewed for two more seasons on May 10, 2019. The series was renewed for seasons 16 and 17, with lead actress Ellen Pompeo extending her contract for two seasons.

If you look at the data for the fifteenth season compared to the previous season, it saw a decrease. After all these years, the popularity of the series remains incredible, but all good things must come to an end.

Isnt Shonda Rhimes, Anatomys producer working with Netflix?

We know since July 2018 that Shonda Rhimes has signed an exclusive production agreement with Netflix that will see the launch of eight shows written and produced by those in Shondaland.

Netflix has made a great effort to get some of the most talented producers to provide content for its streaming service. Shonda is now one of the many talented producers who are creating new products for Netflix.

Continue reading here:
Greys Anatomy Season 16: When Is It Scheduled For Netflix Release? Premiere Date And Other Details - The Digital Weekly

9 Grey’s Anatomy Actors Who Acted Like Total Jerks On Set (11 Surprising Sweethearts) – TheThings

Greys Anatomy has been around since 2005 and is still being aired to this day by ABC, the show made it to 16 seasons and has no signs of slowing down. The American TV medical drama has become the longest-running scripted primetime show on the network to date and the series success quickly sparked an incredible fan base and a massive amount of loyal viewers tuning in week after week.

Ever since the launch of the show, we have fallen in love with both the characters and the cast working behind the scenes. We are looking forward to seeing what producer Shonda Rhimes has in store for us for the highly anticipated 17th season of the series. The Emmy-winning drama has famously experienced its fair share of drama and scandals within its last 16 years, on and off-screen. Here are9 Grey's Anatomy Actors Who Acted Like Total Jerks On Set and 11 sweethearts.

Ever since the very beginning of the show, Patrick Dempsey has been known for his diva behavior on set. Things seemed to have gotten worse throughout the years and finally, the actor departed in 2015. Dempsey was let go before his contract was even up and was rumored to have left due to a messy affair with a staff member.

Sandra Oh's role on the show earned her several awards and a massive payday. She is not only one of the funniest cast members on set but also one of the most dedicated actresses. In an interview with Glamours Kevin McKidd said " She has notes all over her scripts, and then Chandra rearranges them! Drives her crazy!"

It was rumored that Isaiah Washington got in a heated fight on set with one of his co-stars. In an extremely dramatic incident, Isaiah allegedly had co-star Patrick Dempsey by the throat. That is not the only time Isaiah has lost control while in an argument with Dempsey. In 2007, Washington used a homophobic slur during another heated exchange with his co-star.

In an interview with Glamour, when asked "Which cast member is always in a good mood at 5 a.m. call times? Sarah Drew was quick to respond "Jerrika Hinton. She has a lot of energy and is super enthusiastic". Camilla Ludding totally agreed, she answered "Jerrika Hinton has an energy about her at 5 A.M. that nobody should have. It should be illegal!"

In an interview with Larry King, a Grey's Anatomy cast member suggested that T.R. Knight solely made claims that the homophobic slur used by Isaiah Washington during an argument with Patrick Dempsey was about him, in an attempt to advance his career and get more money because he was displeased with Shonda Rhimes and his lack of screen time. Ultimately, Knight left the show after the conclusion of season five.

In a cast interview for E! News, everyone agreed Denzel Washington was one of the most memorable guest directors on set. Everyone on the show gushed about how awesome it was to get to work with the famous actor. He directed the episode "The Sound Of Silence" for the ninth episode of the twelfth season.

Justin Chambers is possibly one of the funniest actors on set, Sarah Drew even admitted to Glamour that Justin definitely had the most difficulty memorizing medical jargon, "Honestly, you can see it in every blooper reel in every season! There's five minutes devoted to him saying, "What's my line?!" We all die laughing." she said.

Since joining the hit TV show back in 2008 for Grey's Anatomy's 5th season, Jessica Capshaw has always been described by her co-stars as jolly and cheerful just like her quirky on-screen character, Dr.Arizona Robbins. It is not a shocker that the actress is a real-life sweetheart on set too!

Back in 2008, Katherine Heigl withdrew herself from the Emmy nominations for her portrayal of the Grey Anatomy's beloved character, Izzie stevens. The incident would not have been so controversial however the actress publicly made a statement announcing the fact that she did not feel that she was given the material that season to warrant an Emmy nomination. Talk about ungrateful.

Bokhee has appeared as a background character in every season of Grey's Anatomy, she is featured in most surgeries on-screen and is a real surgical nurse off-screen too. Sandra Oh took to twitter to write about her heart of gold, twitting Shes been with us since the beginning. Shes like my 2nd mom, shes the best.

Usually known as the funny guy on set, Jesse Williams was been portraying character Jackson Avery, M.D. on ABC's medical drama Grey's Anatomy for over a decade! In an interview with The Hollywood Reporter, the cast revealed that this funny guy is notoriously known to break character quite often during his co-star's scenes. Yikes!

Through 16 seasons of Grey's Anatomy, fans have loved watching Ellen Pompeo evolve into an award-worthy actress, she has been the heart of show since the very beginning. In real life, Pompeo is fighting for equality for women in the workplace and in 2017, she signed a new deal that made her dramatic television's highest-earning actress.

Ellen Pompeo is one of the most beloved cast members on the Grey's Anatomy franchise but when Shonda Rhimes gave Kate Walsh's character her own spin-off show called Private Practice, the cast seemed instantly resentful towards Walsh. There was a rumor that Ellen Pompeo was particularly upset about her co-star's new show. Humble much?

When Sarah Drew left the show after the series 14th season, she left her castmates heartbroken as she is easily one of the most beloved actresses on set. Jesse Williams even took to twitter "Their [Drew and Jessica Capshaw] immense talent speaks for itself but it's them as people that I'm so grateful to know, privileged to have worked with and learned from"

Sara Ramirez first appearing in Season two of Grey's Anatomy and quickly became a regular by season three. She worked on the show for over 10 years up until season 12 when Ramirez abruptly left after wrapping up shooting. It was reported by Vulture that producer Shonda Rhimes only knew Ramirez was leaving the show 3 days before the general public found out. Harsh.

Giacomo Gianniotti's real-life counterpart seems to be just as sweet and lovable as his character Andrew Deluca on the hit medical series Grey's Anatomy. The actor is well known for his charity work and was even joined by his castmates in a fundraiser that helps raise money and bring awareness to today's homeless youth in Los Angeles.

After 6 years of playing Mark Sloan on the ABC's hit medical series, Eric Dane was booted from the show. He has openly expressed in the past, not only his dissatisfaction with his role but also his distaste for the series creator, Shonda Rhimes. He told the news outlet Programme TV that "...I was just a piece of meat", he also used unnecessary profanity to dismiss Shonda's opinions on twitter. Not cool.

Chandra Wilson is a loving cast member and devoted mother. She used her own life experience with her sick daughter to inspire an episode of Grey's Anatomy, she used her platform to help families going through the same struggles. She has a reputation for keeping her on set behavior low-key and drama-free for the past 15 years.

Melissa's drama may not have taken place on set, but her questionable actions definitely got fan's attention. In 2017, George attempted to take her young children with her to the U.S. after a court ruled that she and her boyfriend would have shared custody, Melissa eventually faced kidnapping charges for the stunt.

Camilla Luddington joined the show as the recurring character in season 9 but quickly became a fan favorite in the series. There is no doubt that Camilla is incredibly involved with her fans, she takes time out of her hectic schedule to answer as many questions she can on social media.

Next10 Former WCW Stars That Are Banned From WWE (And 7 Vince Surprisingly Loves)

Read this article:
9 Grey's Anatomy Actors Who Acted Like Total Jerks On Set (11 Surprising Sweethearts) - TheThings

It Is the Time to Think About a Treat-to-Target Strategy for Knee Oste | TCRM – Dove Medical Press

A Migliore,1 G Gigliucci,1 RJ Petrella,2 RR Bannuru,3 X Chevalier,4 E Maheu,5 R Raman,6 G Herrero-Beaumont,7 N Isailovic,8 M Matucci Cerinc9

1Rheumatology Unit, San Pietro Fatebenefratelli Hospital, Rome, Italy; 2Department of Family Medicine, School of Kinesiology Western University, Western Centre for Public Health & Family, London, Ontario, Canada; 3Center for Treatment Comparison and Integrative Analysis Division of Rheumatology, Tufts Medical Center, Boston, MA, USA; 4Department of Rheumatology, Hpital Henri Mondor, Creteil, France; 5Rheumatology Department, AP-HP, Saint-Antoine Hospital, Paris, France; 6Academic Department of Orthopaedics, Hull and East Yorkshire NHS Trust, Castle Hill Hospital, Cottingham, UK; 7Joint and Bone Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain; 8Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano, Milan, Italy; 9Division of Rheumatology AOUC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

Correspondence: N IsailovicDivision of Rheumatology and Clinical Immunology, Humanitas Research Hospital, Via A. Manzoni 56, Rozzano 20089, Milan, ItalyTel +39-02-8224-5118Email natasa.isailovic@humanitasresearch.it

Abstract: Osteoarthritis (OA) is a rheumatic disease that affects the well-being of the patient, compromises physical and mental function, and affects other quality of life aspects. In the literature, several evidence-based guidelines and recommendations for the management of knee osteoarthritis (KOA) are available. These recommendations list the different therapeutic options rather than addressing a hierarchy between the treatments and defining the real target. Therefore, a question arises: are patients and physicians satisfied with the current management of KOA? Actually, the answer may be negative, thus suggesting a change in our therapeutic strategies. In this article, we address this challenge by suggesting that it is time to develop a treat to target strategy for KOA.

Keywords: osteoarthritis, knee osteoarthritis, treat to target

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

More:
It Is the Time to Think About a Treat-to-Target Strategy for Knee Oste | TCRM - Dove Medical Press

Omalizumab Improves Lung Function in Adolescents With Uncontrolled Asthma – Pulmonology Advisor

Omalizumab may significantly improve lung function in adolescents with moderate to severe uncontrolled asthma, according to study results published in the Annals of Allergy, Asthma, and Immunology.

Omalizumab is a humanized monoclonal antibody against immunoglobulin E that was approved for the treatment of asthma in 2013 and has demonstrated significant improvement in lung function in adolescents in real-world studies. However, the effect of omalizumab on the lung function of adolescent patients in placebo-controlled trials has not been established. Therefore, researchers assessed the effect of omalizumab on lung function and eosinophil counts in adolescents aged 12 to 17 years with uncontrolled moderate to severe allergic asthma using a post-hoc analysis of 8 randomized trials. Of 340 adolescents, 203 received omalizumab and 137 received placebo.

Omalizumab increased all baseline lung function variables more than placebo by the end of the study (3.0% [P =.035], 120.9 mL [P =.009], and 101.5 mL [P =.033] for percent predicted forced expiratory volume in 1 second [FEV1], absolute FEV1, and forced vital capacity, respectively). In addition, the least squares mean difference demonstrated a greater reduction in eosinophil counts with omalizumab compared with placebo (P =.001).

The significant improvements in lung function observed in patients receiving omalizumab emphasize the potential effect of omalizumab in patients who remain uncontrolled on current therapies and the need to optimize treatment early in the disease course, the researchers concluded.

Disclosure: This clinical trial was supported by Genentech, Inc., a member of the Roche Group and Novartis Pharma AG. Please see the original reference for a full list of authors disclosures.

Reference

Busse WW, Humbert M, Haselkorn T, et al. Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma [published online November 21, 2019]. Ann Allergy Asthma Immunol. doi:10.1016/j.anai.2019.11.016

View post:
Omalizumab Improves Lung Function in Adolescents With Uncontrolled Asthma - Pulmonology Advisor

Study finds mechanism for mother-child transmission of immunity to chickenpox – Down To Earth Magazine

New finding takes understanding on how babies are protected against infections such as chickenpox to a different level

Women who been infected by chickenpox may transmit the DNA of the disease-causing virus to their babiesduring pregnancy, stimulatingtheirimmunity against the infection and protecting them, a study found.

This mother-to-child transfer of viral DNA may be responsible for long-lasting protection against chickenpox infection seen during childhood, researchers from National Institute of Immunology and St Stephens Hospital, Delhi, said. Their study was published in journal Viral Immunology.

The new finding takes the understanding on how babies are protected against infections such as chickenpox to a new level.

Currently, it isunderstood that mothers provide babies protection against a variety of common infections by transferring readymade antibodies to them. The protection lasts for 12-15 months; if a baby catches an infection during this period, it gets ill in a mild form and develops its own long-lasting immunity for that disease.

The new study led by Jacob Puliyel from St Stephens Hospital showed that it was, however, different in the case of chickenpox. Scientists found that mothers developedsubclinical viremia and the viral DNA was transferred to their babies. The study was done in 350 mothers and their newborn babies.

The babies of mothers, who had chickenpox earlier in their life, develop a long-lasting active immunity with the transfer of chickenpox DNA from mothers, instead of the short-term passive protection provided by the transfer of readymade antibodies. It is likely that the antibodies are developed actively in the foetus, researchers said.

Several studies have already shown that chickenpox can get reactivated due to stress following surgeries and space travel. But, subclinical reactivation of chickenpox, induced by the stress of pregnancy, is being reported for the first time, they added.

Further, they said the chickenpox parties held in countries like in the United Kingdom to get childrenexposed to others with chickenpoxwas not necessarily a bad idea. They got naturally infected in childhood, when the disease was typically mild, and later in life they were likely to pass on protectingchickenpox antibodies and DNA to their offspring.

The new findings make a case for review of vaccination policies for chickenpox, the authors said.

Besides Puliyel, the team consisted of Alaknanda Mishra, Ashwani Kesarwani, K Varsha Mohan and Pramod Upadhyay of National Institute of Immunology and Vivek Ranjan and Sandeep Narayan Lal of St Stephens Hospital. (India Science Wire)

We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.

Read more:
Study finds mechanism for mother-child transmission of immunity to chickenpox - Down To Earth Magazine

Rheos Medicines Announces Worldwide Collaboration with Roche to Discover and Develop Novel Medicines in the Field of Immunometabolism – Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rheos Medicines (Rheos), a biopharmaceutical company harnessing insights in immunometabolism to create a new class of therapeutics for patients with severe autoimmune disorders, inflammatory diseases and cancer, today announced that it has entered into a worldwide exclusive collaboration, option and license agreement with Roche to discover, develop and commercialize novel therapeutics in the field of immunometabolism.

We are thrilled to be leveraging our expertise in human immune cell metabolism in partnership with Roche, said Barbara Fox, Chief Executive Officer of Rheos. We believe that our teams deep experience in immunology and cellular metabolism along with our unique approach have the potential to unlock a new frontier in precision medicine for immune mediated disease. This partnership will help to accelerate the translation of insights in immunometabolism to the development of groundbreaking therapeutics for patients with autoimmune and inflammatory diseases.

"We are excited to partner with Rheos and look forward to the development of a novel class of therapeutics for patients with autoimmune and inflammatory disease, said Gijs van den Brink, SVP and Global Head of Immunology, Infectious Diseases and Ophthalmology at Roche Pharma Early Research and Development. "We believe Rheos' proprietary platform and expertise in immunometabolism is a strong complement to Roche's expertise in autoimmunity and inflammation and in developing and commercializing innovative therapies."

Under the terms of the agreement, Rheos will conduct an exclusive research effort to identify novel targets in immunometabolism that modify the fate or function of certain human immune cells. In addition, Rheos will also be responsible for drug discovery efforts under the collaboration. Roche will receive an option to exclusively license a defined number of programs emerging from the collaboration. For certain products within the collaboration, Rheos and Roche could share worldwide development and US commercial rights.

Rheos will receive an upfront cash payment of $42.5 million upon execution and will be eligible to receive up to approximately $90 million for specified research and preclinical development milestones as well as option fees. Rheos will also be eligible to receive up to an additional approximately $660 million in specified development, regulatory and sales related milestones across the programs and tiered royalties on net sales. For those products for which Rheos and Roche could share development and commercial rights Rheos will be entitled to additional financial compensation within the US and ex- US commensurate with the share of its financial investment in development and commercialization.

About Rheos Medicines

Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop novel therapeutics for patients with severe autoimmune disorders, inflammatory diseases and cancer. Our approach targets the underlying intracellular metabolism of immune cells and has the potential to unlock a new frontier in drug discovery for immune-mediated disease. Through a proprietary platform and product engine that integrates multiple omic datasets, we systematically define the biologic links between immune cell metabolism and function and simultaneously identify new drug targets and biomarkers of disease to bring precision to the treatment of immune-mediated diseases. We have assembled leading scientists whose discoveries opened the field of immunometabolism, clinicians with a deep understanding of immune-mediated diseases, and an experienced biotech leadership team. Rheos was founded by Third Rock Ventures and is located in Cambridge, MA. For more information, please visit http://www.rheosrx.com.

Continue reading here:
Rheos Medicines Announces Worldwide Collaboration with Roche to Discover and Develop Novel Medicines in the Field of Immunometabolism - Business Wire

A hero of the early days of AIDS – The Australian Jewish News

PROFESSOR Ron Penny, the man who diagnosed the first case of AIDS in Australia in 1982 and a leading researcher in the field, died overnight.

Penny and his family arrived in Australia in 1938 after fleeing the Nazis in Poland.It was that family history that defined in his career.

After diagnosing a gay man of having AIDS, he fought hard against the discrimination that followed in Australia.

The political issue was not AIDS itself; it was the discrimination and the repercussions of the way the straight community thought about gay men, Penny told The Sydney Morning Herald in the early 2000s.

The attitude was they caused it themselves, it is due to their lifestyle, and I saw that as a very dangerous process.

Being Jewish I think I understand discrimination my family left Poland because of the antisemitism and I could see that it was just the same story with different names.

Ron Penny (left), pictured with United Nations Special Commission chair Richard Butler.

Penny, who was St Vincents Hospitals Centre for Immunology inaugural director and went on to become one of Australias most influential scientists, made it his mission to defend the human rights of individuals.

I was trying to kill all those stories that you can get it from touching the handrail on a public bus, you can get it from going to the hairdressers, from gay men breathing on you or shaking hands.

Penny was honoured by many in his field and the community as a pioneer.

Don Baxter, the former head of the Australian Federation of AIDS Organisations said Penny was a strong leader and more than just a doctor in the early days of the AIDS epidemic.

He knew when to take risks and be publicly critical of the [health] minister commonwealth or state and when not to he was very much an activist.

Former federal health minister Neal Blewett said Penny was one of the heroes of the early days of HIV.

He was quite self-effacing and quite modest and I perhaps didnt realise how valuable he was.

Ron Penny, third from right, at a NSW Jewish Board of Deputies function to honour the St Vincents hospital.

In 2008, while chair of the NSW Governments Chronic, Aged and Community Health Priority task force, and a member of the NSW Health Care Advisory Committee, Penny was appointed to the Federal Governments National Health and Hospital Reform Commission

In 1993 the Commonwealth recognised Penny with an Officer of the Order of Australia (AO) for his service to medical research and education, particularly in the field of clinical immunology.

Get The AJN Newsletter by email and never miss our top storiesFree Sign Up

The rest is here:
A hero of the early days of AIDS - The Australian Jewish News

The neuroscience behind remembering the past and plotting the future – Brandeis University

A new study by psychologist Shantanu Jadhav and his lab shines new light on how rats make decisions based on recent memories.

During sleep, the brain replays each memory from the day in a unique pattern of brain cell firings. The activation of a pattern essentially creates a recording of the memory so it can be stored for the long term.

This process, called memory consolidation, occurs while were awake, too. In a recent paper in Neuron, assistant professor of psychology Shantanu Jadhav and his lab demonstrate how memory consolidation works in rats brains when they make a decision.

With remarkable precision, Jadhav and his team identified and isolated specific patterns of brain cell firings in the animals that corresponded to individual memories. As a result, they could tell what the rodents were remembering. They also found a way to predict what the animals would do next.

In the long term, researchers hope that a greater understanding of how the brain processes memories will lead to treatments for diseases where memory is impaired, such as Alzheimers or other kinds of dementia.

The experiment

Jadhav and his collaborators designed a W-shaped maze. Each prong of the W held small wells with a tasty rat treat. A rat entering the maze on the right would find the nearest treat in the center. After that, the nearest treat would be on the left.

It worked in the opposite direction as well; after noshing on the left, the rodent went to the center and then back to the right. Over the course of 6 to 8 hours, the rats formed separate memories of each of the four parts of a roundtrip journey right to center, center to left, left to center and center to right. Each part corresponded to a unique and identifiable pattern of brain cell firings.

Decision time for the rats

When the rats arrived in the center of the maze, they paused for several seconds. During this time, they pondered their next move. They could go back to where they came from (no treat) or they could continue to the opposite side of the W (treat!).

The scientists monitored the rats decision-making process in real-time. First, the rats replayed the sequence of brain cell firings from a memory of one of the four legs of their journey.

But what surprised the scientists was that the rats' brains played the sequence in reverse order, rewinding the recording of the memory. This process is called reverse replay and enables the rats to recall the past in order to decide what to do next.

The rats also pondered their future. Here, the rats played their memories brain cell firings in the original order in which they occurred in a process called forward replay.

Reverse and forward replay occur in the hippocampus, a seahorse-shaped structure located close to the brain's center. (It actually means seahorse in Greek.) The hippocampus handles spatial memory, which in both rats and humans makes it possible to determine location and navigation from place to place. "It's the internal GPS system for navigation in the mammalian brain," Jadhav said.

The brain firings involved in reverse and forward replay are called sharp-wave ripples. In both rats and humans, they happen in bursts that last a few hundred milliseconds a good thing. It may take an hour to go to work, but if recalling the memory of your route took that long youd never return home.

What will the rat do next?

Jadhav and his fellow researchers wanted to see if they could predict the rats route by analyzing their brain cell firings. They observed that the rats final decision on what route to take next didn't happen in the hippocampus, which only sifted through the options. It was in the prefrontal cortex, located behind the forehead, where the animals future path was determined.

The researchers matched activity in the prefrontal cortex to the four brain firing patterns that occurred during the rats journey. Whichever patterns wound up being activated by the prefrontal cortex indicated the route the animal would travel.

Just before the animals moved on from the center, Jadhav and his team observed the pattern fire, enabling them to foresee the rats' next move. "We could actually predict the rats' future," Jadhav said.

Brandeis graduate students Justin D. Shin and Wenbo Tang co-authored the Neuron paper.This research was funded by the National Institutes of Health, the Alfred P. Sloan Foundation and the Whitehall Foundation.

Read the original post:
The neuroscience behind remembering the past and plotting the future - Brandeis University

When Neuroscience Interjects Itself into Debates on Sexuality – Merion West

(PEDRO ARMESTRE/AFP/GettyImages)

The concept is called reverse inference. Its both neurosciences greatest ambition, and the origin of its most frustratingly breathless overstatements.

Every so often, a person is unexpectedly thrust into a defining wedge-issue of an era. This time, I was asked rhetorically, Is being gay a choice? Well, my friend answered their own question; according to a series of studies, including one published inScientific Reportsin 2018, scientists have discovered neurological differences between gay and straight people. When subjects were shown a series of pornographic pictures, depending on the content of the images, people with different sexual orientations had different brain activity. In other words, there is a concrete biological origin of sexuality; there is such a thing as a gay or straight brainrather, a biologically-inevitably gay or straight brain.

As my friend concluded from this development, this proves that being gay is not simply psychological; theres an actual biology to it. Those in right-wing chatrooms trying to mock gay people by saying things to the effect of, I want to be a frog, therefore, Im a frog are now, scientifically verifiably, jerks. Just as one cant just decide to be a frog, one cannot simply claim to be gay and then, poof, become gay.

Without science, if someone states his or her sexual preference, either he or she is telling the truth or making it up. Either a person is gay or theyre pretending to be. With science, however, maybe this debate can be resolved for good.

Personally, I do not have a strong position on whenin the course of ones developmenta person starts being gay. Ive seen scientific arguments for genetic destiny, but Im also drawn to the idea that sexual preference is slowly shaped by an interplay of genetic and social factors throughout adolescence and even into adulthood.

I do, however, have a position on whether brain-imaging research supports the conclusion that being gay is a biological-inevitability. More importantly, I have a position on whether scientific research can inform our moral obligations towards supporting gay rights. In this essay, I hope to show that in specific, neuroscientific terms, we do not know with much confidence what being gay really is. Furthermore, even if we did, science cannot resolve the LGBTQ-rights aspect of the culture wars.

Brain Imaging Does Not Prove Biological Causation, and, Being LGBT is, in General, More than Sexual Orientation

Despite the involvement of extremely complex brain-recording technology, the design of the 2018 experiment was very simple. Scientists collected a group of people who were gay and another group of people who were straight, positioned them in a brain scanner, and showed them pornography. While the subjects awkwardly looked at naked bodies, researchers collected images of their brain activity, and, lo and behold, discovered that some areas of the brain showed differences.

However, one big issue is that straight people and gay people do not differ just in sexuality. There are also (in general) differences in personalities and lifestyles. What if the brain differences seen in this study are really just differences in social presentation? If being gay is (often) more than sexual preference, we cant be confident that the neurological differences are strictly about sexuality.

This confound is not unique just to studies dealing with sexuality. The way we conduct brain-imaging today struggles to prove causation in a traditional scientific sense. Before scientists are willing to adopt the term causation, they want to see that the manipulation of some variable has an impact on another. In other words, changing X reliably changes Y. Sure, we can compare brain activity between groups; however, we cannot intervene in a way that truly mimics what were recording.

The problem is two-fold. Commonly-used brain-recording technologies like EEG and fMRI do not offer very precise resolution. Instead, they record from large swaths of brain tissue. With these technologies, we can evaluate whether a large population of cells are more of less activebut not what any individual cell is doing. Its not clear whether neuroscience actually needs to know the functionality of each cell, but its clear that our recording technology provides highly ambiguous information.

The second half of the problem lies with the difficulty with brain stimulation. Non-invasive stimulation technologies (like transcranial magnetic stimulation) can be done pretty easily, but these technologies also lack precise resolution. In this case, even if our recording technologies provide un-ambiguous data, we could not intentionally produce that same activity pattern.

If we could reproducibly induce gay or straight preferences, we would know with real confidence that we had discovered the biological basis of homosexuality. Tangentially, if we had the technical capacity to change a persons sexual orientation, it would open up a pandoras box of ethical dilemmas (should a parent have the right to convert their child?). Fortunately, this horror scenariolike Mike Pences conversion-camp fantasyis well beyond our technical capabilities.

A Bigger Problem; Neurosciences Persistent Fallacy

Perhaps, though, we ought to try a thought experiment. Lets say its a little bit in the future, and a son just announced to his father that he is, in fact, gay. The father decides that he needs some verification, and, as such, the father takes his son to see the local scientist. The scientist explains that long ago, researchers identified the neural correlates to being gay, as described above, using the round-up and scan method. The scientist then tells the father that he can place the son in the scanner, and, after a short while, determine whether his brain has the characteristics that make his brain gay.

Neuroscientists have long hoped that a persons mental state could be inferred based on the findings of a brain scan. What Russell Poldrack and many other neuroscientists have argued, however, is that this approach relies on questionable reasoning. If we understand a persons psychology, the argument goes, we can also identify the underlying neurology. Just throw the person in a brain-scanner, and theres your answer. However, going one step furthertaking that newly discovered neurologyand inferring that same psychology in a different person is something of a logical leap.

X Y does not imply Y X, because sometimes, maybe, Z Y. Also, some Xs are Ys does not imply that all Xs are Ys.

Its pretty simple. Scientists might be able to observe that gay people, on average, have one sort of brain. But not every gay persons brain is going to appear gay. Furthermore, some non-gay people may have brains that appear gay, even if they are not gay. The differences that scientists observe in the brain are based on group averages; they almost never perfectly distinguish between two groups of people, and, in the case of the study linked here, they did not appear to. The concept is called reverse inference. Its both neurosciences greatest ambition, and the origin of its most frustratingly breathless overstatements.

However, enlightened neuroscientists do note that reverse inference is not necessarily wrong, and, at times, it may be useful. Even if we cannot be 100% sure that a particular brain region underlies a particular trait, maybe we can be 95% sure. Oftentimes, the correlations we find with brain imaging research are suggestive. Nevertheless, especially in situations where there is some variability in the neurobiology (which, is basically, every brain scan study), people need to be very cautious in making that final reverse inference.

Conclusion

Neuroscience cannot tell us much about psychology without relying on current psychological measures. In order to conduct research, we have to have some operational definitions. In this caseif we want to identify the neural correlates of being gaywe have to rely on whether people say theyre gay. Self-report is a premise of the argument, which means that science is not well-prepared to transcend self-report. If a person states that he or she is gay, neuroscience is generally not in a position to elaborate.

As a scientist, I believe in the importance of science-advocacy, and I agree with the sentiment that much evil originates from humankinds attempts to define and divide our species into various categories. I also believe that sexuality does not have to be a rigid unchanging quality defined at birth.

However, in this case, we are likely placing solidarity-signaling over neutral scientific reasoning. Confidently asserting the existence of inevitably-gay-brains might make for the ultimate alliance with the LGBTQ community, but it may overstate the confidence of our science. Scientists are allying with the LGBTQ community certainly not because of political identity, no, but because its rational to do, in their viewbecause its scientific to do so.

But some political questions transcend objective reality. Whether climate change is happening is science, whether we should do something about it isnt. Whether or not we believe that a society ought to embrace homosexuality, or a government ought to protect LGBTQ rights, is a moral question, not a scientific one.The underlying scientific reality can inform our position on whether we support gay rights, but its only part of the equation.

Andrew Neff lectures in psychology at Rochester University and runs the blog Neuroscience From Underground.

See the article here:
When Neuroscience Interjects Itself into Debates on Sexuality - Merion West

What Mice Watching Orson Welles’s Touch of Evil Can Teach Scientists about Vision – Scientific American

The filmgoers didnt flinch at the scene of the dapper man planting a time bomb in the trunk of the convertible, or tense up as the unsuspecting driver and his beautiful blonde companion drove slowly through the town teeming with pedestrians, or jump out of their seats when the bomb exploded in fiery carnage. And they sure as heck werent wowed by the technical artistry of this famous opening shot of Orson Welles 1958 noir masterpiece, Touch of Evil, a single three-minute take that ratchets up the suspense to 11 on a scale of 1 to 10.

In fairness, lab mice arent cineastes. But where the rodents fell short as film critics they more than delivered as portals into the brain. As the mice watched the film clip, scientists eavesdropped on each ones visual cortex. By the end of the study, the textbook understanding of how the brain sees had been as badly damaged as the Touch of Evil convertible, scientistsreportedon Monday.

The new insights into the workings of the visual cortex, they said, could improve technologies as diverse as self-driving cars and brain prostheses to let the blind see.

Neuroscience lets us make better object recognition systems for, say, self-driving cars and artificial intelligence-based diagnostics, said Joel Zylberberg of York University, an expert on machine learning and neuroscience who was not involved in the new research. But computer vision has been hampered by an insufficient understanding of visual processing in the brain. The unprecedented findings in the new study, he said, promise to change that.

The textbook understanding of how the brain sees, starting with streams of photons landing on the retina, reflects research from the 1960s that won two of its pioneers aNobel prizein medicine in 1981. It basically holds that neurons in the primary visual cortex, where the signals go first, respond to edges: vertical edges, horizontal edges, and every edge orientation in between, moving and static. We see a laptop screen because of how its edges abut whats behind it, sidewalks because of where their edges touch the curbs. Higher-order brain systems take these rudimentary perceptions and process them into the perception of a scene or object.

Its been known for more than a decade that this textbook model is partly wrong and largely incomplete, said neurobiologist Saskia de Vries of the Allen Institute for Brain Science, who led the mouse-vision study. To see if she could do better, she and her colleagues showed mice simple gratings (lots of edges), moving gratings,118 photos, and the Touch of Evil opening, recording the resulting electrical activity from hundreds of neurons in six regions of each mouses visual cortex.

Which visual features neurons responded to showed that the textbook model doesnt hold up very well, de Vries said. Only about 10% of the mices visual neurons responded to specific kinds of edges (straight or tilted, horizontal or vertical, sharp or blurry, fat or slender) as per the textbook version of the visual cortex, she and her colleagues reported in Nature Neuroscience. Instead, some responded only to movements of facial muscles, others to several features rather than to a single kind of edge. Yet others, they speculate, might even respond to sounds.

Touch of Evil elicited responses from the greatest number of neurons. That makes sense. In Welles opening scene, the camera zooms in and pans out, it sweeps across the scene, and different people and objects move into and out of the frame, a smorgasbord of imagery that should cover just about everything a visual cortex might need to process. But textbooks say that fewer neurons respond to complex visual scenes than to the simpler, edge-based elements the scenes are made of. The Allen Institute team found the opposite: Static gratings interested the fewest neurons; Welles had a much bigger fan base.

All told, 77% of neurons throughout the mices visual cortex responded to at least one thing the scientists showed them. But in some neighborhoods, only 33% did. The rest seemed to be on strike.

Thats not supposed to happen either. Thats a huge finding, said neuroscientist Bruno Olshausen of the University of California, Berkeley, who hasarguedthat neuroscience understands no more than 20% of how the visual cortex actually operates. Every visual neuron supposedly responds tosomekind of edge, so what are these silent neurons doing? Olshausen asked. Assuming the finding isnt an artifact, thats a huge population of [visual] neurons that arent doing vision. This should be a wake up call to everyone in the field. Something is dramatically wrong with the standard model.

The surprise finding, he added, makes this a tour de force and a first in neuroscience, to systematically characterize such a large population of neurons across different layers, areas and using different stimuli. The data will be invaluable to theorists and modelers for years to come.

It could be that the scientists didnt show the mice images with the particular feature that these unresponsive visual neurons notice. But that seems unlikely, given the diversity of images: butterflies, leopards, fences, mountains, trees, leaves, rocks, sidewalks, windows, staircases, pencils, and more. Instead, de Vries said, I think its a reflection that other things are going on in the visual cortex, like visual neurons processing sound or something else non-visual.

Since machine-vision developers take their cues from how brains see, the Allen Institute results, if confirmed, carry an important message, Yorks Zylberberg said. It shows that there isnt a mess of [undifferentiated neurons] doing all the same thing, which is what we put into our systems now. Instead, theres at least 10 different types of visual neurons that respond to specific aspects of the visual worlda complexity that computerized object-recognition systems might profitably emulate.

As for the scientists choice of flicks, we picked Touch of Evil because we were looking for a movie clip that had a lot of diverse motion without camera cuts, de Vries said.

Republished with permission from STAT. This article originally appeared on December 16 2019

Original post:
What Mice Watching Orson Welles's Touch of Evil Can Teach Scientists about Vision - Scientific American